BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29729227)

  • 21. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
    [No Abstract]   [Full Text] [Related]  

  • 24. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(38):62687-62696. PubMed ID: 27409676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
    Chin-Hsiao T
    Aging Dis; 2019 Feb; 10(1):37-48. PubMed ID: 30705766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
    Tseng CH
    BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
    Tseng CH
    Front Med (Lausanne); 2020; 7():592901. PubMed ID: 33693008
    [No Abstract]   [Full Text] [Related]  

  • 30. Metformin and primary bone cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Bone; 2021 Oct; 151():116037. PubMed ID: 34116220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.
    Tseng CH
    Diabetes Metab; 2019 Oct; 45(5):458-464. PubMed ID: 31129317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.
    Tseng CH
    Front Endocrinol (Lausanne); 2022; 13():1036885. PubMed ID: 36277720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients.
    Tseng CH
    Ther Adv Endocrinol Metab; 2019; 10():2042018819895159. PubMed ID: 31897287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Eur J Endocrinol; 2021 Feb; 184(2):299-310. PubMed ID: 33270043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Front Pharmacol; 2020; 11():578831. PubMed ID: 33664665
    [No Abstract]   [Full Text] [Related]  

  • 38. Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients.
    Tseng CH
    J Clin Med; 2018 Sep; 7(9):. PubMed ID: 30205606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
    Tseng CH
    Clin Breast Cancer; 2017 Jun; 17(3):211-218. PubMed ID: 27986440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients.
    Tseng CH
    Aging (Albany NY); 2019 May; 11(9):2724-2734. PubMed ID: 31085804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.